170108-07-3 Usage
Uses
Used in Pharmaceutical Industry:
Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) is used as a key intermediate in the synthesis of various pharmaceutical substances. Its unique structure, which includes a benzenoid ring with a carboxylic ester and an amino group, makes it a valuable component in the development of new drugs.
Used in Drug Synthesis:
Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) is employed as a building block in the production of pharmaceuticals, contributing to the creation of novel drug molecules with potential therapeutic applications. Its reactivity and structural features allow for the formation of diverse chemical entities that can be further optimized for specific medical uses.
Used in Research and Development:
Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) is utilized in research settings to explore its potential applications and properties. Scientists and researchers use Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) to investigate its interactions with biological systems and to develop new methodologies for its synthesis and application in drug discovery.
It is important to handle Benzoic acid, 2-amino-3,4-difluoro-, methyl ester (9CI) with care due to its reactivity, ensuring that it is used safely and effectively in the development and production of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 170108-07-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,1,0 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 170108-07:
(8*1)+(7*7)+(6*0)+(5*1)+(4*0)+(3*8)+(2*0)+(1*7)=93
93 % 10 = 3
So 170108-07-3 is a valid CAS Registry Number.
170108-07-3Relevant academic research and scientific papers
QUINAZOLINONES AS PARP14 INHIBITORS
-
Paragraph 0242; 0255, (2019/07/10)
The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.
QUINAZOLINE COMPOUNDS USEFUL AS M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
, (2017/09/27)
The present invention is directed to compounds of Formula (I): (Formula (I)) and pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R7, R8, R9, R11, n and p are defined herein. The compounds of Formula (I) are M1 receptor positive allosteric modulators that are useful in the treatment of diseases in which the M1 receptor is involved, including Alzheimer's disease, schizophrenia, pain and sleep disorders. The invention also relates to pharmaceutical compositions comprising a compound of Formula (I) and a pharmaceutically acceptable carrier, and to methods of using the compounds of Formula (I) in the treatment of diseases mediated by the M1 receptor.
